Shree Pacetronix Limited has formally responded to BSE Limited's surveillance department regarding queries about recent movements in its share price. The company's clarification, dated 10th April, 2026, addresses concerns raised by the exchange about price volatility in the stock.

Company's Response to BSE Query

The cardiac pacing technology company received an email communication from BSE on 9th April, 2026, seeking clarification on recent price movements. In its response, Shree Pacetronix emphasized that it has consistently informed the exchange about all events and information impacting company operations and performance.

Market-Driven Price Movement

The company attributed the share price movement to prevailing market conditions, stating that such fluctuations are "purely due to market conditions and apparently market driven." Shree Pacetronix clarified that it neither has control over nor knowledge of specific reasons behind market-driven price movements.

Regulatory Compliance Commitment

Shree Pacetronix reiterated its adherence to regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed its commitment to:

• Timely disclosure of price-sensitive information
• Compliance with Regulation 30 requirements
• Keeping stock exchanges informed of material events
• Maintaining transparency in corporate communications

The response was digitally signed by Joint Managing Director Akash Sethi on 10th April, 2026, reinforcing the company's commitment to regulatory compliance and transparent communication with market participants and exchanges.

Shree Pacetronix Limited has completed significant equity transactions involving promoter Akash Sethi, who has filed comprehensive regulatory disclosures under SEBI regulations. Following a recent warrant conversion and a substantial off-market share acquisition, the promoter's shareholding has increased substantially, triggering mandatory disclosure requirements under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Major Share Acquisition Transaction

Akash Sethi acquired 1,65,355 equity shares through an off-market transfer from Bio Pace Technology INC on March 20, 2026. This acquisition represents a significant increase in the promoter's equity holding, raising his shareholding percentage from 4.35% to 8.76% of the company's total share capital.

Official SEBI Regulatory Filing

The company submitted the official disclosure to BSE Limited on March 24, 2026, signed by Company Secretary Rupali Ahire. The filing was made pursuant to Regulation 29(2) of the SEBI (SAST) Regulations following the intimation received from promoter Akash Sethi regarding his substantial acquisition.

Detailed Shareholding Analysis

The comprehensive SEBI disclosure reveals the complete shareholding pattern before and after the acquisition. Prior to this transaction, Akash Sethi held 1,63,116 equity shares representing 4.35% of the total share capital along with 1,50,300 warrants.

Capital Structure Details

The company's current paid-up equity share capital stands at ₹3,74,97,000, consisting of 37,49,700 equity shares of ₹10 face value each. The total diluted share capital, including potential warrant conversions, amounts to ₹3,90,00,000 comprising 39,00,000 equity shares.

Regulatory Compliance

The entire transaction was conducted in full compliance with SEBI regulations, with proper documentation submitted to BSE Limited. Akash Sethi, serving as Promoter and Joint Managing Director with DIN 08176396, signed the detailed disclosure from Pithampur, Madhya Pradesh. The filing includes comprehensive breakdowns of voting rights, warrant holdings, and diluted shareholding calculations as mandated under regulatory guidelines.